Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: Hope on the horizon for patients with severe systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 64, Issue 10, 2005, Pages 1515-

  Van Laar, J M ^a   Farge, D ^b   Tyndall, A ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAINT LOUIS HOSPITAL   (France)

^c Felix Platter Spital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; MYELOABLATIVE CONDITIONING; NOTE; PRIORITY JOURNAL; REMISSION; RHEUMATIC DISEASE; RISK FACTOR; SCLERODERMA; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ARTICLE; CONTROLLED CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; RANDOMIZED CONTROLLED TRIAL;

CYCLOPHOSPHAMIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS; SCLERODERMA, SYSTEMIC;

EID: 27744586941     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.043240     Document Type: Note

References (0)